Wells Fargo Maintains Overweight on Boston Scientific, Raises Price Target to $82
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Larry Biegelsen maintains an Overweight rating on Boston Scientific (NYSE:BSX) and raises the price target from $72 to $82.
April 25, 2024 | 2:19 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wells Fargo has maintained an Overweight rating on Boston Scientific and increased the price target from $72 to $82.
The upgrade in the price target by a reputable analyst like Larry Biegelsen suggests a strong confidence in Boston Scientific's future performance. This is likely to be viewed positively by the market, potentially leading to a short-term increase in the stock price.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100